Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Treasury Shares (2025)

CG Oncology's Treasury Shares history spans 1 years, with the latest figure at $166342.0 for Q4 2025.

  • For Q4 2025, Treasury Shares changed N/A year-over-year to $166342.0; the TTM value through Dec 2025 reached $166342.0, changed N/A, while the annual FY2025 figure was $166342.0, N/A changed from the prior year.
  • Treasury Shares reached $166342.0 in Q4 2025 per CGON's latest filing, up from $94624.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $166342.0 in Q4 2025 to a low of $94624.0 in Q3 2025.